Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids

被引:19
作者
Bajotto, G
Murakami, T
Nagasaki, M
Qin, B
Matsuo, Y
Maeda, K
Ohashi, M
Oshida, Y
Sato, Y
Shimomura, Y [1 ]
机构
[1] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan
[2] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan
[3] Aichi Gakuin Univ, Dept Hlth Sci, Nisshin 4700195, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 03期
关键词
D O I
10.1016/j.metabol.2005.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The activity of the pyruvate dehydrogenase complex (PDC) is regulated by covalent modification of its E I component, which is catalyzed by specific pyruvate dehydrogenase kinases (PDKs) and phosphatases. In the liver, PDK2 and PDK4 are the most abundant PDK isoforms, which are responsible for inactivation of PDC when glucose availability is scarce in the body. In the present study, regulatory mechanisms of hepatic PDC were examined before and after the onset of type 2 diabetes mellitus in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, using Long-Evans Tokushima Otsuka (LETO) rats as controls. Plasma glucose and insulin concentrations were at normal levels in rats aged 8 weeks, but were significantly higher in OLETF than in LETO rats aged 25 weeks, indicating insulin resistance in OLETF rats. Plasma free fatty acids (FFAs) were 1.6-fold concentrated, and the liver PDC activity was significantly lower in OLETF than in LETO rats at both ages, suggesting suppression of pyruvate oxidative decarboxylation in OLETF rats before and after the onset of diabetes. Pyruvate dehydrogenase kinase activity and abundance of PDK2 and PDK4 proteins, as well as mRNAs, were greater in OLETF rats at both ages. These results suggest that persistently elevated levels Of circulating free fatty acid in normal and diabetic OLETF rats play air important role in stimulating PDK2 and PDK4 expression in liver. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 29 条
[1]   Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus [J].
Bajotto, G ;
Murakami, T ;
Nagasaki, M ;
Tamura, T ;
Tamura, N ;
Harris, RA ;
Shimomura, Y ;
Sato, Y .
LIFE SCIENCES, 2004, 75 (17) :2117-2130
[2]  
BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433
[3]   Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex [J].
Bowker-Kinley, MM ;
Davis, WI ;
Wu, PF ;
Harris, RA ;
Popov, KM .
BIOCHEMICAL JOURNAL, 1998, 329 :191-196
[4]   AN IMPROVEMENT IN THE PYRUVATE-DEHYDROGENASE COMPLEX ASSAY - A HIGH-YIELD METHOD FOR PURIFYING ARYLAMINE ACETYLTRANSFERASE [J].
BROOKS, SPJ ;
STOREY, KB .
ANALYTICAL BIOCHEMISTRY, 1993, 212 (02) :452-456
[5]   Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta [J].
Forman, BM ;
Chen, J ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4312-4317
[6]   Regulation of the activity of the pyruvate dehydrogenase complex [J].
Harris, RA ;
Bowker-Kinley, MM ;
Huang, BL ;
Wu, PF .
ADVANCES IN ENZYME REGULATION, VOL 42, PROCEEDINGS, 2002, 42 :249-259
[7]   EFFECTS OF INCREASED PLASMA FATTY-ACIDS ON GLYCOGEN UTILIZATION AND ENDURANCE [J].
HICKSON, RC ;
RENNIE, MJ ;
CONLEE, RK ;
WINDER, WW ;
HOLLOSZY, JO .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (05) :829-833
[8]   Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding [J].
Holness, MJ ;
Kraus, A ;
Harris, RA ;
Sugden, MC .
DIABETES, 2000, 49 (05) :775-781
[9]   Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone [J].
Holness, MJ ;
Bulmer, K ;
Smith, ND ;
Sugden, MC .
BIOCHEMICAL JOURNAL, 2003, 369 :687-695
[10]   Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-α ligands, glucocorticoids, and insulin [J].
Huang, BL ;
Wu, PF ;
Bowker-Kinley, MM ;
Harris, RA .
DIABETES, 2002, 51 (02) :276-283